nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—SLC16A1—Methotrexate—colon cancer	0.508	1	CbGbCtD
Gamma Hydroxybutyric Acid—SLC52A2—embryo—colon cancer	0.0196	0.131	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—bone marrow—colon cancer	0.0112	0.0747	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—vagina—colon cancer	0.0108	0.0716	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—epithelium—colon cancer	0.00956	0.0635	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—smooth muscle tissue—colon cancer	0.00921	0.0612	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—liver—colon cancer	0.00909	0.0604	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—renal system—colon cancer	0.00887	0.0589	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—digestive system—colon cancer	0.00727	0.0483	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—lymph node—colon cancer	0.00697	0.0463	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—bone marrow—colon cancer	0.0067	0.0445	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—vagina—colon cancer	0.00613	0.0407	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—epithelium—colon cancer	0.00581	0.0386	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—liver—colon cancer	0.00542	0.036	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—renal system—colon cancer	0.00539	0.0358	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—liver—colon cancer	0.00517	0.0343	CbGeAlD
Gamma Hydroxybutyric Acid—GABRB1—vagina—colon cancer	0.00493	0.0327	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—digestive system—colon cancer	0.00442	0.0293	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—lymph node—colon cancer	0.00415	0.0276	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—lymph node—colon cancer	0.00396	0.0263	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—liver—colon cancer	0.00329	0.0219	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—lymph node—colon cancer	0.00252	0.0168	CbGeAlD
Gamma Hydroxybutyric Acid—Blood creatinine increased—Capecitabine—colon cancer	0.00107	0.00314	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Irinotecan—colon cancer	0.00107	0.00313	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Irinotecan—colon cancer	0.00107	0.00313	CcSEcCtD
Gamma Hydroxybutyric Acid—Dehydration—Capecitabine—colon cancer	0.00107	0.00312	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Vincristine—colon cancer	0.00107	0.00312	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Irinotecan—colon cancer	0.00106	0.00311	CcSEcCtD
Gamma Hydroxybutyric Acid—Mouth ulceration—Methotrexate—colon cancer	0.00106	0.00311	CcSEcCtD
Gamma Hydroxybutyric Acid—Bladder pain—Methotrexate—colon cancer	0.00106	0.00311	CcSEcCtD
Gamma Hydroxybutyric Acid—Ecchymosis—Methotrexate—colon cancer	0.00106	0.00311	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Irinotecan—colon cancer	0.00105	0.00306	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain upper—Capecitabine—colon cancer	0.00105	0.00306	CcSEcCtD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00103	0.00302	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Capecitabine—colon cancer	0.00103	0.003	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Vincristine—colon cancer	0.00102	0.003	CcSEcCtD
Gamma Hydroxybutyric Acid—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00101	0.00296	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscular weakness—Capecitabine—colon cancer	0.00101	0.00296	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Fluorouracil—colon cancer	0.001	0.00294	CcSEcCtD
Gamma Hydroxybutyric Acid—Lymphadenopathy—Methotrexate—colon cancer	0.001	0.00293	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Irinotecan—colon cancer	0.000998	0.00292	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal distension—Capecitabine—colon cancer	0.000998	0.00292	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Irinotecan—colon cancer	0.000992	0.0029	CcSEcCtD
Gamma Hydroxybutyric Acid—Influenza—Capecitabine—colon cancer	0.000991	0.0029	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Vincristine—colon cancer	0.000979	0.00287	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Vincristine—colon cancer	0.000973	0.00285	CcSEcCtD
Gamma Hydroxybutyric Acid—Sweating increased—Capecitabine—colon cancer	0.000965	0.00282	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Irinotecan—colon cancer	0.000953	0.00279	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Vincristine—colon cancer	0.000952	0.00279	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Fluorouracil—colon cancer	0.000931	0.00273	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Irinotecan—colon cancer	0.000927	0.00271	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Irinotecan—colon cancer	0.000925	0.00271	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Vincristine—colon cancer	0.000918	0.00269	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Vincristine—colon cancer	0.000915	0.00268	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Fluorouracil—colon cancer	0.000913	0.00267	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Irinotecan—colon cancer	0.000907	0.00265	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Vincristine—colon cancer	0.000902	0.00264	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Capecitabine—colon cancer	0.000902	0.00264	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight decreased—Capecitabine—colon cancer	0.000896	0.00262	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Capecitabine—colon cancer	0.000894	0.00262	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Irinotecan—colon cancer	0.000891	0.00261	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Capecitabine—colon cancer	0.000883	0.00259	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Capecitabine—colon cancer	0.000883	0.00259	CcSEcCtD
Gamma Hydroxybutyric Acid—Depression—Capecitabine—colon cancer	0.000881	0.00258	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Vincristine—colon cancer	0.000864	0.00253	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Capecitabine—colon cancer	0.000861	0.00252	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Vincristine—colon cancer	0.000859	0.00251	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Fluorouracil—colon cancer	0.000856	0.00251	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Irinotecan—colon cancer	0.000849	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Vincristine—colon cancer	0.000848	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Capecitabine—colon cancer	0.000842	0.00247	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Irinotecan—colon cancer	0.000842	0.00246	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Fluorouracil—colon cancer	0.000841	0.00246	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Fluorouracil—colon cancer	0.000841	0.00246	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Irinotecan—colon cancer	0.000836	0.00245	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Vincristine—colon cancer	0.000836	0.00245	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Capecitabine—colon cancer	0.000833	0.00244	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Irinotecan—colon cancer	0.000828	0.00242	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Irinotecan—colon cancer	0.000826	0.00242	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Vincristine—colon cancer	0.000824	0.00241	CcSEcCtD
Gamma Hydroxybutyric Acid—Irritability—Methotrexate—colon cancer	0.000815	0.00238	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Irinotecan—colon cancer	0.000814	0.00238	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Fluorouracil—colon cancer	0.000813	0.00238	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Fluorouracil—colon cancer	0.000806	0.00236	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Irinotecan—colon cancer	0.000803	0.00235	CcSEcCtD
Gamma Hydroxybutyric Acid—Ataxia—Methotrexate—colon cancer	0.000802	0.00235	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Fluorouracil—colon cancer	0.000801	0.00234	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Capecitabine—colon cancer	0.000795	0.00233	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Fluorouracil—colon cancer	0.000791	0.00231	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Capecitabine—colon cancer	0.000789	0.00231	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Vincristine—colon cancer	0.000788	0.00231	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Capecitabine—colon cancer	0.000787	0.0023	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Capecitabine—colon cancer	0.000783	0.00229	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Vincristine—colon cancer	0.000782	0.00229	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Capecitabine—colon cancer	0.000781	0.00229	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Capecitabine—colon cancer	0.000779	0.00228	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Capecitabine—colon cancer	0.000777	0.00228	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Vincristine—colon cancer	0.000776	0.00227	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Fluorouracil—colon cancer	0.000769	0.00225	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Irinotecan—colon cancer	0.000761	0.00223	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Irinotecan—colon cancer	0.000756	0.00221	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Vincristine—colon cancer	0.000751	0.0022	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Irinotecan—colon cancer	0.000751	0.0022	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Irinotecan—colon cancer	0.000748	0.00219	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Vincristine—colon cancer	0.000746	0.00218	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Vincristine—colon cancer	0.000745	0.00218	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Capecitabine—colon cancer	0.000741	0.00217	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Irinotecan—colon cancer	0.000741	0.00217	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Capecitabine—colon cancer	0.000739	0.00216	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Vincristine—colon cancer	0.000739	0.00216	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Vincristine—colon cancer	0.000739	0.00216	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Capecitabine—colon cancer	0.000736	0.00215	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000735	0.00215	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Irinotecan—colon cancer	0.000732	0.00214	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Fluorouracil—colon cancer	0.000729	0.00213	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Irinotecan—colon cancer	0.000727	0.00213	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Irinotecan—colon cancer	0.000726	0.00212	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Fluorouracil—colon cancer	0.000724	0.00212	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Irinotecan—colon cancer	0.00072	0.00211	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Irinotecan—colon cancer	0.00072	0.00211	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Capecitabine—colon cancer	0.00072	0.00211	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Fluorouracil—colon cancer	0.000719	0.0021	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Fluorouracil—colon cancer	0.000717	0.0021	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Capecitabine—colon cancer	0.000716	0.0021	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Capecitabine—colon cancer	0.000715	0.00209	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Capecitabine—colon cancer	0.000712	0.00208	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Fluorouracil—colon cancer	0.00071	0.00208	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Vincristine—colon cancer	0.000707	0.00207	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Fluorouracil—colon cancer	0.000701	0.00205	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Capecitabine—colon cancer	0.000701	0.00205	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000696	0.00204	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Capecitabine—colon cancer	0.000695	0.00203	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Irinotecan—colon cancer	0.000694	0.00203	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Capecitabine—colon cancer	0.00069	0.00202	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Fluorouracil—colon cancer	0.00069	0.00202	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Irinotecan—colon cancer	0.000688	0.00201	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Vincristine—colon cancer	0.000683	0.002	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Capecitabine—colon cancer	0.000676	0.00198	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Capecitabine—colon cancer	0.000668	0.00195	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Irinotecan—colon cancer	0.000666	0.00195	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Fluorouracil—colon cancer	0.000664	0.00194	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Capecitabine—colon cancer	0.000664	0.00194	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Methotrexate—colon cancer	0.000658	0.00192	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Methotrexate—colon cancer	0.000658	0.00192	CcSEcCtD
Gamma Hydroxybutyric Acid—Depression—Methotrexate—colon cancer	0.000656	0.00192	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Capecitabine—colon cancer	0.000651	0.0019	CcSEcCtD
Gamma Hydroxybutyric Acid—Tremor—Capecitabine—colon cancer	0.000647	0.00189	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Methotrexate—colon cancer	0.000641	0.00188	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Fluorouracil—colon cancer	0.000641	0.00187	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Capecitabine—colon cancer	0.000638	0.00187	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Vincristine—colon cancer	0.000637	0.00186	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Methotrexate—colon cancer	0.000627	0.00184	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Methotrexate—colon cancer	0.00062	0.00182	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Capecitabine—colon cancer	0.00062	0.00182	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Irinotecan—colon cancer	0.00062	0.00182	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Vincristine—colon cancer	0.00062	0.00182	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Capecitabine—colon cancer	0.000619	0.00181	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Capecitabine—colon cancer	0.00061	0.00179	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Capecitabine—colon cancer	0.000607	0.00178	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Irinotecan—colon cancer	0.000604	0.00177	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Capecitabine—colon cancer	0.000596	0.00174	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Fluorouracil—colon cancer	0.000594	0.00174	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Vincristine—colon cancer	0.000591	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Capecitabine—colon cancer	0.000588	0.00172	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Capecitabine—colon cancer	0.000588	0.00172	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Capecitabine—colon cancer	0.000588	0.00172	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Methotrexate—colon cancer	0.000586	0.00171	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Capecitabine—colon cancer	0.000586	0.00171	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000584	0.00171	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Methotrexate—colon cancer	0.000583	0.00171	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Methotrexate—colon cancer	0.000579	0.00169	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Irinotecan—colon cancer	0.000576	0.00169	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Capecitabine—colon cancer	0.000575	0.00168	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Vincristine—colon cancer	0.000572	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Capecitabine—colon cancer	0.000568	0.00166	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Capecitabine—colon cancer	0.000563	0.00165	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Capecitabine—colon cancer	0.00056	0.00164	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Irinotecan—colon cancer	0.000557	0.00163	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Capecitabine—colon cancer	0.000554	0.00162	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Capecitabine—colon cancer	0.000553	0.00162	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Methotrexate—colon cancer	0.000552	0.00161	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Fluorouracil—colon cancer	0.000552	0.00161	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Methotrexate—colon cancer	0.00055	0.00161	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Vincristine—colon cancer	0.00055	0.00161	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Methotrexate—colon cancer	0.000548	0.0016	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Capecitabine—colon cancer	0.000547	0.0016	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Vincristine—colon cancer	0.000545	0.0016	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Capecitabine—colon cancer	0.000545	0.00159	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Vincristine—colon cancer	0.000545	0.00159	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Vincristine—colon cancer	0.000542	0.00159	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Capecitabine—colon cancer	0.000537	0.00157	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Methotrexate—colon cancer	0.000536	0.00157	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Irinotecan—colon cancer	0.000535	0.00157	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Methotrexate—colon cancer	0.000533	0.00156	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Fluorouracil—colon cancer	0.000533	0.00156	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Methotrexate—colon cancer	0.000532	0.00156	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Irinotecan—colon cancer	0.000531	0.00155	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Irinotecan—colon cancer	0.00053	0.00155	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Methotrexate—colon cancer	0.00053	0.00155	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Irinotecan—colon cancer	0.000527	0.00154	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Methotrexate—colon cancer	0.000522	0.00153	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Methotrexate—colon cancer	0.000517	0.00151	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Methotrexate—colon cancer	0.000514	0.0015	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Vincristine—colon cancer	0.000513	0.0015	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000513	0.0015	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Fluorouracil—colon cancer	0.000513	0.0015	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Capecitabine—colon cancer	0.00051	0.00149	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Fluorouracil—colon cancer	0.000508	0.00149	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Fluorouracil—colon cancer	0.000508	0.00149	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Capecitabine—colon cancer	0.000506	0.00148	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Fluorouracil—colon cancer	0.000505	0.00148	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Methotrexate—colon cancer	0.000503	0.00147	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Capecitabine—colon cancer	0.000502	0.00147	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Irinotecan—colon cancer	0.0005	0.00146	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Methotrexate—colon cancer	0.000497	0.00146	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Capecitabine—colon cancer	0.000496	0.00145	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Capecitabine—colon cancer	0.00049	0.00143	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Capecitabine—colon cancer	0.000486	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Capecitabine—colon cancer	0.000486	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Methotrexate—colon cancer	0.000484	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Capecitabine—colon cancer	0.000482	0.00141	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Capecitabine—colon cancer	0.000482	0.00141	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Fluorouracil—colon cancer	0.000479	0.0014	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Methotrexate—colon cancer	0.000475	0.00139	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Capecitabine—colon cancer	0.000464	0.00136	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Methotrexate—colon cancer	0.000462	0.00135	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Capecitabine—colon cancer	0.000461	0.00135	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Capecitabine—colon cancer	0.000448	0.00131	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Capecitabine—colon cancer	0.000445	0.0013	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Methotrexate—colon cancer	0.000445	0.0013	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Methotrexate—colon cancer	0.000438	0.00128	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Methotrexate—colon cancer	0.000438	0.00128	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Methotrexate—colon cancer	0.000438	0.00128	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000435	0.00127	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Methotrexate—colon cancer	0.000423	0.00124	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Methotrexate—colon cancer	0.000417	0.00122	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Capecitabine—colon cancer	0.000415	0.00122	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Methotrexate—colon cancer	0.000411	0.0012	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Methotrexate—colon cancer	0.000407	0.00119	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Methotrexate—colon cancer	0.000406	0.00119	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Capecitabine—colon cancer	0.000404	0.00118	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Methotrexate—colon cancer	0.0004	0.00117	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Capecitabine—colon cancer	0.000386	0.00113	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000382	0.00112	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Methotrexate—colon cancer	0.000379	0.00111	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Methotrexate—colon cancer	0.000377	0.0011	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Methotrexate—colon cancer	0.000374	0.00109	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Methotrexate—colon cancer	0.000373	0.00109	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Capecitabine—colon cancer	0.000373	0.00109	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Methotrexate—colon cancer	0.000369	0.00108	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Methotrexate—colon cancer	0.000365	0.00107	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Methotrexate—colon cancer	0.000362	0.00106	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Methotrexate—colon cancer	0.000362	0.00106	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Methotrexate—colon cancer	0.000359	0.00105	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Capecitabine—colon cancer	0.000358	0.00105	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Capecitabine—colon cancer	0.000355	0.00104	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Capecitabine—colon cancer	0.000355	0.00104	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Capecitabine—colon cancer	0.000353	0.00103	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Methotrexate—colon cancer	0.000346	0.00101	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Methotrexate—colon cancer	0.000343	0.001	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Capecitabine—colon cancer	0.000335	0.00098	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Methotrexate—colon cancer	0.000333	0.000975	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Methotrexate—colon cancer	0.000332	0.00097	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Methotrexate—colon cancer	0.000309	0.000904	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Methotrexate—colon cancer	0.000301	0.000881	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Methotrexate—colon cancer	0.000287	0.00084	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Methotrexate—colon cancer	0.000277	0.000812	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Methotrexate—colon cancer	0.000267	0.000781	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Methotrexate—colon cancer	0.000264	0.000774	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Methotrexate—colon cancer	0.000264	0.000773	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Methotrexate—colon cancer	0.000263	0.000769	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Methotrexate—colon cancer	0.000249	0.000729	CcSEcCtD
